GenoLogics and Bioinformatics Solutions Collaborate
News May 25, 2006
GenoLogics Life Sciences Software Inc. and Bioinformatics Solutions Inc. (BSI) have announced the two companies are collaborating to provide an integrated solution for proteomics researchers.
GenoLogics and BSI are partnering to integrate GenoLogics’ Proteus™ lab and data management solution, with BSI’s PEAKS software for peptide sequencing and protein identification from tandem mass spectrometry (MS/MS) data.
Customers with both solutions in their lab environment will use Proteus to generate and manage the data from their MS, and PEAKS to automatically submit spectra data, with the results captured by Proteus for simplified collaboration and visualization.
"The integration of PEAKS with Proteus improves the overall value of the solution we can provide to our customers, simplifying lab workflow and accelerating results generation," commented James DeGreef, Founder and VP Product Management for GenoLogics.
"Lab researchers can now take advantage of our workflow and data management solution to quickly retrieve and manage MS sample information, and use PEAKS to obtain the complete sequence for each peptide under investigation, enabling high-throughput analysis."
"This integration is a good example of the value GenoLogics’ open software platform brings to life science researchers and systems biology discovery."
According to Iain Rogers, Business Development Manager for BSI, "Researchers are demanding robust, flexible, automated delivery and creation of results."
"If you don’t have to worry about putting your hammer’s head and handle together …[you] can get on with banging nails in quite happily."
"The collaboration between GenoLogics and BSI means researchers can get on with the real business of scientific discovery."
"Both organizations are committed to providing proteomics researchers with software required for protein and peptide analysis."
GenoLogics (booth #95) and Bioinformatics Solutions (booth #92) will both be exhibiting at the ASMS conference in Seattle, May 28 – June 1, 2006.
‘Good Cholesterol’ May Not Always be Good for Postmenopausal WomenNews
Postmenopausal factors may have an impact on the heart-protective qualities of high-density lipoproteins (HDL) – also known as ‘good cholesterol’ – according to a study led by researchers in the University of Pittsburgh Graduate School of Public Health.READ MORE
What Makes Good Brain Proteins Turn Bad?News
The protein FUS is implicated in two neurodegenerative diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). Using a newly developed fruit fly model, researchers have zoomed in on the protein structure of FUS to gain more insight into how it causes neuronal toxicity and disease.